High γ-radiation sensitivity is associated with increased gastric cancer risk in a Chinese Han population: A case-control analysis

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Dong, Honglin ^a   Jin, Xiaowei ^b   Hu, Jie ^a   Li, Haifeng ^a   He, Xianli ^c   Liu, Xiaonan ^d   Bao, Guoqiang ^c  

^a SHANXI MEDICAL UNIVERSITY   (China)

^b AIR FORCE GENERAL HOSPITAL   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^d FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DOSIMETRY; FEMALE; GAMMA RADIATION; HIGH RISK POPULATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PERIPHERAL LYMPHOCYTE; RADIATION EXPOSURE; RADIOSENSITIVITY; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SMOKING; STOMACH CANCER;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHROMATIDS; ETHNIC GROUPS; FEMALE; GAMMA RAYS; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; RADIATION TOLERANCE; RISK; STOMACH NEOPLASMS;

EID: 84865159385     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043625     Document Type: Article

References (46)

1. Setiawan VW, Zhang ZF, Yu GP, Lu QY, Li YL, et al. ((2001)) GSTP1 polymorphisms and gastric cancer in a high-risk Chinese population. Cancer Causes Control 12:: 673--681.
2. Hung RJ, Hall J, Brennan P, Boffetta P, ((2005)) Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am J Epidemiol 162:: 925--942.
3. Au WW, Salama SA, ((2005)) Use of biomarkers to elucidate genetic susceptibility to cancer. Environ Mol Mutagen 45:: 222--228.
4. Chung CC, Chanock SJ, ((2011)) Current status of genome-wide association studies in cancer. Hum Genet 130:: 59--78.
5. Malik MA, Upadhyay R, Mittal RD, Zargar SA, Modi DR, et al. ((2009)) Role of xenobiotic-metabolizing enzyme gene polymorphisms and interactions with environmental factors in susceptibility to gastric cancer in Kashmir Valley. J Gastrointest Cancer 40:: 26--32.
6. Gu D, Wang M, Wang S, Zhang Z, Chen J, ((2011)) The DNA repair gene APE1 T1349G polymorphism and risk of gastric cancer in a Chinese population. PLoS One 6:: e28971.
7. Abnet CC, Freedman ND, Hu N, Wang Z, Yu K, et al. ((2010)) A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet 42:: 764--767.
8. Spitz MR, Wu X, Jiang H, Hsu TC (1996) Mutagen sensitivity as a marker of cancer susceptibility. J Cell Biochem Suppl 25: 80-84.
9. El-Zein RA, Schabath MB, Etzel CJ, Lopez MS, Franklin JD, et al. ((2006)) Cytokinesis-blocked micronucleus assay as a novel biomarker for lung cancer risk. Cancer Res 66:: 6449--6456.
10. Shen H, Spitz MR, Qiao Y, Guo Z, Wang LE, et al. ((2003)) Smoking, DNA repair capacity and risk of nonsmall cell lung cancer. Int J Cancer 107:: 84--88.
11. Shao L, Lin J, Huang M, Ajani JA, Wu X, ((2005)) Predictors of esophageal cancer risk: assessment of susceptibility to DNA damage using comet assay. Genes Chromosomes Cancer 44:: 415--422.
12. Spitz MR, Fueger JJ, Beddingfield NA, Annegers JF, Hsu TC, et al. ((1989)) Chromosome sensitivity to bleomycin-induced mutagenesis, an independent risk factor for upper aerodigestive tract cancers. Cancer Res 49:: 4626--4628.
13. Hsu TC, Spitz MR, Schantz SP, ((1991)) Mutagen sensitivity: a biological marker of cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1:: 83--89.
14. Spitz MR, Hsu TC, Wu X, Fueger JJ, Amos CI, et al. ((1995)) Mutagen sensitivity as a biological marker of lung cancer risk in African Americans. Cancer Epidemiol Biomarkers Prev 4:: 99--103.
15. Wang LE, Hsu TC, Xiong P, Strom SS, Duvic M, et al. (2006) 4-Nitroquinoline-1-Oxide-Induced Mutagen Sensitivity and Risk of Nonmelanoma Skin Cancer: A Case-Control Analysis. J Invest Dermatol.
16. Wang LE, Sturgis EM, Eicher SA, Spitz MR, Hong WK, et al. ((1998)) Mutagen sensitivity to benzo (a) pyrene diol epoxide and the risk of squamous cell carcinoma of the head and neck. Clin Cancer Res 4:: 1773--1778.
17. Buchholz TA, Wu X, ((2001)) Radiation-induced chromatid breaks as a predictor of breast cancer risk. Int J Radiat Oncol Biol Phys 49:: 533--537.
18. Wu X, Gu J, Patt Y, Hassan M, Spitz MR, et al. ((1998)) Mutagen sensitivity as a susceptibility marker for human hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev 7:: 567--570.
19. Bondy ML, Wang LE, El-Zein R, de Andrade M, Selvan MS, et al. ((2001)) Gamma-radiation sensitivity and risk of glioma. J Natl Cancer Inst 93:: 1553--1557.
20. Erdei E, Lee SJ, Wei Q, Wang LE, Song YS, et al. ((2006)) Reliability of mutagen sensitivity assay: an inter-laboratory comparison. Mutagenesis 21:: 261--264.
21. Gianfagna F, De Feo E, van Duijn CM, Ricciardi G, Boccia S, ((2008)) A systematic review of meta-analyses on gene polymorphisms and gastric cancer risk. Curr Genomics 9:: 361--374.
22. Xia HH, Wong BC, Wong WM, Tang VS, Cheung HK, et al. ((2002)) Optimal serological tests for the detection of Helicobacter pylori infection in the Chinese population. Aliment Pharmacol Ther 16:: 521--526.
23. Cherry LM, Hsu TC, ((1983)) Bleomycin-induced chromosome damage in lymphocytes of medullary thyroid carcinoma patients and their family members. Anticancer Res 3:: 367--372.
24. Hsu TC, Cherry LM, Samaan NA, ((1985)) Differential mutagen susceptibility in cultured lymphocytes of normal individuals and cancer patients. Cancer Genet Cytogenet 17:: 307--313.
25. Wang LE, Bondy ML, de Andrade M, Strom SS, Wang X, et al. ((2000)) Gender difference in smoking effect on chromosome sensitivity to gamma radiation in a healthy population. Radiat Res 154:: 20--27.
26. Lee JJ, Trizna Z, Hsu TC, Spitz MR, Hong WK, ((1996)) A statistical analysis of the reliability and classification error in application of the mutagen sensitivity assay. Cancer Epidemiol Biomarkers Prev 5:: 191--197.
27. Natarajan TG, Ganesan N, Carter-Nolan P, Tucker CA, Shields PG, et al. ((2006)) gamma-Radiation-induced chromosomal mutagen sensitivity is associated with breast cancer risk in African-American women: caffeine modulates the outcome of mutagen sensitivity assay. Cancer Epidemiol Biomarkers Prev 15:: 437--442.
28. Wang LE, Han CH, Xiong P, Bondy ML, Yu TK, et al. (2012) Gamma-ray-induced mutagen sensitivity and risk of sporadic breast cancer in young women: a case-control study. Breast Cancer Res Treat.
29. Wang LE, Xiong P, Strom SS, Goldberg LH, Lee JE, et al. ((2005)) In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis. J Natl Cancer Inst 97:: 1822--1831.
30. Gajecka M, Jarmuzs M, Szyfter W, Szyfter K, ((2004)) Non-random distribution of chromatid breaks in lymphocytes of laryngeal squamous cell carcinoma patients. Oncol Rep 12:: 153--157.
31. Pandita TK, Hittelman WN, ((1995)) Evidence of a chromatin basis for increased mutagen sensitivity associated with multiple primary malignancies of the head and neck. Int J Cancer 61:: 738--743.
32. Hsu TC, ((1983)) Genetic instability in the human population: a working hypothesis. Hereditas 98:: 1--9.
33. Wei Q, Spitz MR, Gu J, Cheng L, Xu X, et al. ((1996)) DNA repair capacity correlates with mutagen sensitivity in lymphoblastoid cell lines. Cancer Epidemiol Biomarkers Prev 5:: 199--204.
34. Berwick M, Vineis P, ((2000)) Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst 92:: 874--897.
35. Wu X, Gu J, Hong WK, Lee JJ, Amos CI, et al. ((1998)) Benzo [a] pyrene diol epoxide and bleomycin sensitivity and susceptibility to cancer of upper aerodigestive tract. J Natl Cancer Inst 90:: 1393--1399.
36. Wu X, Lippman SM, Lee JJ, Zhu Y, Wei QV, et al. ((2002)) Chromosome instability in lymphocytes: a potential indicator of predisposition to oral premalignant lesions. Cancer Res 62:: 2813--2818.
37. Xiong P, Bondy ML, Li D, Shen H, Wang LE, et al. ((2001)) Sensitivity to benzo (a) pyrene diol-epoxide associated with risk of breast cancer in young women and modulation by glutathione S-transferase polymorphisms: a case-control study. Cancer Res 61:: 8465--8469.
38. Hsu TC, Johnston DA, Cherry LM, Ramkissoon D, Schantz SP, et al. ((1989)) Sensitivity to genotoxic effects of bleomycin in humans: possible relationship to environmental carcinogenesis. Int J Cancer 43:: 403--409.
39. Gu J, Bondy ML, Sigurdson A, Spitz MR, Hsu TC, et al. ((1999)) Three measures of mutagen sensitivity in a cancer-free population. Cancer Genet Cytogenet 110:: 65--69.
40. Cheng L, Guan Y, Li L, Legerski RJ, Einspahr J, et al. ((1999)) Expression in normal human tissues of five nucleotide excision repair genes measured simultaneously by multiplex reverse transcription-polymerase chain reaction. Cancer Epidemiol Biomarkers Prev 8:: 801--807.
41. Seetharam S, Kraemer KH, Waters HL, Seidman MM, ((1991)) Ultraviolet mutational spectrum in a shuttle vector propagated in xeroderma pigmentosum lymphoblastoid cells and fibroblasts. Mutat Res 254:: 97--105.
42. Udumudi A, Jaiswal M, Rajeswari N, Desai N, Jain S, et al. ((1998)) Risk assessment in cervical dysplasia patients by single cell gel electrophoresis assay: a study of DNA damage and repair. Mutat Res 412:: 195--205.
43. Patel RK, Trivedi AH, Arora DC, Bhatavdekar JM, Patel DD, ((1997)) DNA repair proficiency in breast cancer patients and their first-degree relatives. Int J Cancer 73:: 20--24.
44. Hagmar L, Brogger A, Hansteen IL, Heim S, Hogstedt B, et al. ((1994)) Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage. Cancer Res 54:: 2919--2922.
45. Wu X, Spitz MR, Amos CI, Lin J, Shao L, et al. ((2006)) Mutagen sensitivity has high heritability: evidence from a twin study. Cancer Res 66:: 5993--5996.
46. Chao DL, Maley CC, Wu X, Farrow DC, Galipeau PC, et al. ((2006)) Mutagen sensitivity and neoplastic progression in patients with Barrett's esophagus: a prospective analysis. Cancer Epidemiol Biomarkers Prev 15:: 1935--1940.